Page 1,705«..1020..1,7041,7051,7061,707..1,7101,720..»

Texas has sanctioned unapproved stem cell therapies. Will it change anything? – Science Magazine

Posted: Published on June 15th, 2017

Texas Governor Greg Abbott just signed a law making it easier for unproven stem cell therapies to be given to patients in his state. Marjorie Kamys Cotera/Bob Daemmrich Photography/Alamy Stock Photo By Kelly ServickJun. 15, 2017 , 11:15 AM Texas Governor Greg Abbott yesterday signed a bill allowing clinics and companies in the state to offer people unproven stem cell interventions without the testing and approval required under federal law. Like the right to try laws that have sprung up in more than 30 states, the measure is meant to give desperately ill patients access to experimental treatments without oversight from the U.S. Food and Drug Administration (FDA). In a state where unproven stem cell therapies are already offered widely with little legal backlash, bioethicists and patient advocates wonder whether the states official blessing will maintain the status quo, tighten certain protections for patients, or simply embolden clinics already profiting from potentially risky therapies. You could make the argument thatif [the new law] was vigorously enforcedits going to put some constraints in place, says Leigh Turner, a bioethicist at the University of Minnesota in Minneapolis, who last year co-authored a study documenting U.S. stem cell clinics marketing directly to consumers … Continue reading

Posted in Stem Cell Research | Comments Off on Texas has sanctioned unapproved stem cell therapies. Will it change anything? – Science Magazine

Biotechnology company opens mosquito factory in Lexington … – Lexington Herald Leader

Posted: Published on June 15th, 2017

Lexington Herald Leader Biotechnology company opens mosquito factory in Lexington ... Lexington Herald Leader A Lexington biotechnology company aimed at fighting mosquito-borne diseases such as the Zika virus opened a mosquito factory Friday on Malabu Drive. and more » Go here to read the rest: Biotechnology company opens mosquito factory in Lexington ... - Lexington Herald Leader … Continue reading

Posted in Biotechnology | Comments Off on Biotechnology company opens mosquito factory in Lexington … – Lexington Herald Leader

Puma Biotechnology Inc (PBYI) Price Target Raised to $60.00 – The Cerbat Gem

Posted: Published on June 15th, 2017

NormanObserver.com Puma Biotechnology Inc (PBYI) Price Target Raised to $60.00 The Cerbat Gem Puma Biotechnology Inc (NYSE:PBYI) had its price objective increased by Royal Bank Of Canada from $40.00 to $60.00 in a research note published on Thursday, May 25th, MarketBeat Ratings reports. Royal Bank Of Canada currently has a sector perform ... Right After Earnings, The Intelligent Options Trade in Puma Biotechnology IncCML News Puma Biotechnology's (PBYI) Buy Rating Reaffirmed at Stifel NicolausSports Perspectives The Puma Biotechnology Inc (PBYI) Downgraded by Zacks Investment Research to HoldBangaloreWeekly Markets Daily -Transcript Daily -Chaffey Breeze -SEC.gov all 94 news articles » Here is the original post: Puma Biotechnology Inc (PBYI) Price Target Raised to $60.00 - The Cerbat Gem … Continue reading

Posted in Biotechnology | Comments Off on Puma Biotechnology Inc (PBYI) Price Target Raised to $60.00 – The Cerbat Gem

Senate would give high school seniors a break on biology test requirement – The Spokesman-Review

Posted: Published on June 15th, 2017

UPDATED: Wed., June 14, 2017, 12:06 a.m. OLYMPIA Good news for high school seniors unable to pass their biology assessment test: The Senate passed a bill that would let them get their diplomas anyway. But the bad news for those seniors and others who were unable to pass the math or English language assessment test is its different than the House bill. And while it seems likely the Legislature is going to remove that barrier to graduation, the deal isnt done yet. On a 43-to-5 vote, the Senate approved a proposal to drop the requirement that all high school students pass a biology assessment test. The test is typically taken in freshman or sophomore year, at the end of a biology course. Students who fail at that point can retake it multiple times or submit a collection of evidence to show they understand the material. They can also submit a grade above a certain score from the science portion of the ACT test. Even with those options, some 3,300 seniors had not passed the test as of early May and couldnt qualify for a diploma even though they had completed all other requirements. Most schools are allowing those students to … Continue reading

Posted in Biology | Comments Off on Senate would give high school seniors a break on biology test requirement – The Spokesman-Review

Five reasons we’re excited by how structural biology is advancing cancer research – The Institute of Cancer Research (blog)

Posted: Published on June 15th, 2017

A protein model is built into an electron density map, amino acid by amino acid. The result is a snapshot of the protein or protein complex at work. Image courtesy of Dr Sebastian Guettler. Several research teams at the ICR are devoted to structural biology a crucial discipline in cancer research that is shedding light on some of lifes most fundamental processes. We are excited about the potential this field has to enable the discovery of brand new cancer drugs. There are five key reasons why structural biology research excites us: If you want to support our structural biology research, please have a look at our chromatography appeal which will help fund a new, state-of-the-art, chromatography machine. Support our chromatography appeal Structure of RNA polymerase II. Image credit: David Bushnell, Ken Westover and Roger Kornberg, Stanford University. CC BY-NC 2.0. Our structural biologists explore the shapes of proteins in detail, down to the individual atom, and work out how they interlock with other proteins and potential drugs. Proteins are the drivers of all our biological processes, which are hijackedin cancer to drive cell growth and spread. Were interested in finding out what a protein looks like in three dimensions, to … Continue reading

Posted in Biology | Comments Off on Five reasons we’re excited by how structural biology is advancing cancer research – The Institute of Cancer Research (blog)

18th International Congress of Developmental Biology (June 18 22, 2017): Hongyan Wang – PLoS Blogs (blog)

Posted: Published on June 15th, 2017

As part of its mission to encourage engagement within the genetics community, PLOS Genetics is supporting a number of conferences and meetings this year. In order to raise awareness about these conferences and the researchers who attend them, we are featuring a number of these conferences on Biologue, with posts written by the organizers, or the PLOS Genetics editors who are involved. PLOS Genetics will be supporting the 18th International Congress of Developmental Biology (ISDB2017), which will take place at the University Cultural Centre of the National University of Singapore from June 18th 22nd. We asked Hongyan Wang, a member of the local conference programme committee and PLOS Genetics Associate Editor, about the event. Organised by the International Society of Developmental Biologists (ISDB), the quadrennial ISDB congress will bring together over 700 developmental biologists from 35 different countries to share their exciting findings. The lead organiser of the 18th ISDB is Philip Ingham, current president of the ISDB, based in both Singapore and the United Kingdom. Singapore is now recognized as a leading biomedical research hub in Asia, and has a vibrant Developmental Biology research community. It was on this recognition that Philips bid to stage the 2017 Congress was … Continue reading

Posted in Biology | Comments Off on 18th International Congress of Developmental Biology (June 18 22, 2017): Hongyan Wang – PLoS Blogs (blog)

Revealing New Details of Cancer Biology with Automated Kinetic Live Cell Imaging – Bioscience Technology

Posted: Published on June 15th, 2017

Decades of research into characterization, prevention, detection and treatment have substantially expanded our collective understanding of cancer biology. However, these insights elicit a new generation of unanswered questions about the complexity of this group of often-deadly diseases. Historical investigations yielded the key understandings that cancer cells arise from indigenous cells, and most, if not all, tumors are derived from a single parent cell1. In 2000, Hanahan and Weinberg simplified the many aspects of transformation from normal human cells into cancerous ones through six essential cell physiology alterations. These so-called hallmarks of cancer include self-sufficiency in growth signals, insensitivity to anti-growth or inhibitory signals, evasion of apoptosis, unlimited replication capability, sustained angiogenesis, and tissue invasion and metastasis2. They later added deregulating cellular energetics and avoiding immune destruction as emerging hallmarks; genome instability and mutation and tumor-promoting inflammation as enabling characteristics3. The impact of external stimuli, interactions with neighboring cells and the extracellular matrix (ECM), heterogeneity, inherited traits, and other factors further complicate the elucidation of cancer biology. Along with the expanding scope of research interests, methodologies have evolved to include live cell studies in addition to conventional biochemical and fixed cell assays. Live cell assays allow researchers to dynamically study a … Continue reading

Posted in Biology | Comments Off on Revealing New Details of Cancer Biology with Automated Kinetic Live Cell Imaging – Bioscience Technology

Learn details of the global bioinformatics service market – WhaTech

Posted: Published on June 15th, 2017

This report studies the Bioinformatics Service market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Bioinformatics Service market by product and Application/end industries. The global Bioinformatics Service market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. United States will still play an important role which cannot be ignored. EU also play important roles in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of XX. The major players in global market include Baseclear Thermo Fisher Macrogen Clinical Laboratory EcSeq Clinical-Microbiomics MR DNA (Molecular Research Lp) Molzym Zymo Research Rancho Biosciences Microbiome Insights Openbiome Resphera Biosciences Openbiome Resphera Biosciences Shanghai Realbio Technology Diversigen Merieux Nutrisciences Metabiomics Norgen Biotek Rancho BioSciences. Geographically, this report split global into several key Regions, with, … Continue reading

Posted in BioInformatics | Comments Off on Learn details of the global bioinformatics service market – WhaTech

Sandra Oh lands new TV role, three years after quitting 'Grey's Anatomy' – Malay Mail Online

Posted: Published on June 15th, 2017

Sandra Oh takes the lead role in Killing Eve, screening in 2018 on BBC America. AFP picLOS ANGELES, June 15 The Canadian actress, who played surgeon Cristina Yang in Greys Anatomy for nine years, will take the lead role in a new series. Killing Eve will screen in 2018 on BBC America, according to The Hollywood Reporter. Killing Eve is billed as a spy thriller in which Sandra Oh will play Eve, a security services operative whos smart but unfulfilled by her office job, a far cry from the exciting life of a spy she dreams of. However, Eve soon finds herself being hunted by an elegant and talented psychopathic killer. Sandra Oh found fame in 2005 in ABCs medical drama Greys Anatomy. For 10 seasons she played Cristina Yang, a brilliant surgeon and friend of lead character Meredith Grey. Since leaving the show in 2014, the actress has been seen in the most recent season of American Crime. The eight-episode Killing Eve series is created by Phoebe Waller-Bridge, the British writer and actress who wrote and starred in comedy show Fleabag, about the life of a young woman trying to navigate life in London. The series, which screened last … Continue reading

Posted in Anatomy | Comments Off on Sandra Oh lands new TV role, three years after quitting 'Grey's Anatomy' – Malay Mail Online

Researchers aim to repurpose former experimental cancer therapy to treat muscular dystrophy – National Institutes of Health (press release)

Posted: Published on June 14th, 2017

National Institutes of Health (press release) Researchers aim to repurpose former experimental cancer therapy to treat muscular dystrophy National Institutes of Health (press release) ... Sciences (NCATS) and the University of Nevada, Reno School of Medicine (UNR Med) have demonstrated that a drug originally targeted unsuccessfully to treat cancer may have new life as a potential treatment for Duchenne muscular dystrophy (DMD). and more » Originally posted here: Researchers aim to repurpose former experimental cancer therapy to treat muscular dystrophy - National Institutes of Health (press release) … Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Researchers aim to repurpose former experimental cancer therapy to treat muscular dystrophy – National Institutes of Health (press release)

Page 1,705«..1020..1,7041,7051,7061,707..1,7101,720..»